17th Jul 2026 10:42
(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Friday.
----------
FTSE 100 winners
----------
Vodafone Group PLC, up 2.8% at 119.53p, Xavier Niel to grow Vodafone stake to over 18% as e& deal proceeds
Severn Trent PLC, up 2.5% at 3,055.00p
British American Tobacco PLC, up 2.5% at 4,646.00p
Experian PLC, up 2.3% at 2,743.50p
BT Group PLC, up 2.2% at 197.63p, read across from Vodafone
----------
FTSE 100 losers
----------
Burberry Group PLC, down 5.2% at 1,062.00p, US-Iran conflict continues to drag on Middle East sales
Antofagasta PLC, down 4.2% at 3,436.00p
Polar Capital Technology Trust PLC, down 3.8% at 621.50p
Scottish Mortgage Investment Trust PLC, down 3.7% at 1,357.50p
GSK PLC, down 3.2% at 1,892.75p, CALM-2 camlipixant 50mg trial shows "limited efficacy" and "unlikely to transform patient care"
----------
FTSE 250 winners
----------
Ocado Group PLC, up 6.0% at 168.70p
Hays PLC, up 5.0% at 55.63p
Mondi PLC, up 3.1% at 760.50p
PageGroup PLC, up 3.0% at 165.05p
Partners Group Private Equity Ltd, up 2.9% at 755¢
----------
FTSE 250 losers
----------
Ceres Power Holdings PLC, down 9.2% at 345.60p
Wag Payment Solutions PLC, down 7.5% at 99.90p, TA Associates completes GBP30 million sale of Eurowag shares
Raspberry Pi Holdings PLC, down 6.0% at 684.00p
Allianz Technology Trust PLC, down 4.5% at 667.50p
Pacific Horizon Investment Trust PLC, down 4.4% at 1,023.00p
----------
FTSE 100 & 250 movers in focus:
----------
Burberry Group PLC, down 5.2% at 1,062.00 pence, 12-month range 976.00p-1,376.50p. Reports first-quarter retail revenue rises 5.1% to GBP455 million, with comparable store sales up 5%, driven by 12% growth in the Americas and a 9% increase in Greater China. The luxury retailer says growth returns across womenswear, menswear, accessories and childrenswear for the first time in three years, led by double-digit outerwear growth, while handbags and e-commerce also improve. Burberry raises first-half wholesale revenue guidance to high-single-digit growth following strong partner demand and reiterates its full-year outlook, although the war in the Middle East continues to weigh on sales in the EMEIA region.
----------
GSK PLC, down 3.2% at 1,892.75 pence, 12-month range 1,288.60p-2,282.00p. Reports mixed phase 3 results for experimental cough treatment camlipixant, with the Calm-1 trial meeting its primary endpoint at week 12 but the Calm-2 study and the 25mg dose failing to achieve statistical significance. The pharmaceutical company says the overall data demonstrate "limited efficacy" and that the treatment is "unlikely to transform patient care", prompting it to discontinue further development of camlipixant for refractory chronic cough. GSK will, however, continue the phase 2b Balance trial evaluating camlipixant in irritable bowel syndrome.
----------
Vodafone Group PLC, up 2.8% at 119.53 pence, 12-month range 80.68p-131.10p. Says investment vehicle Vega, owned by the family of billionaire telecoms investor Xavier Niel, will acquire Emirates Telecommunications Group's entire 16.2% stake in the company through counterparty banks at 110.48p per share. Following regulatory approvals and settlement of related financial instruments, Vega is expected to increase its holding to around 18.8% of Vodafone's share capital and 19.9% of voting rights, making it the telecoms group's largest shareholder. Vega intends for its Vodafone investment "to be a long-term, strategic minority shareholding." Vega notes that, as it had said last week when it announced its binding agreement to buy e&'s stake, it does not intend to make an offer for Vodafone.
----------
Wag Payment Solutions PLC, down 7.5% at 99.90 pence, 12-month range 87.00p-135.00p. Existing shareholder TA Associates sells a 4.3% stake in the trucking payments firm through a GBP30.0 million placing at 100p per share. The private equity investor retains a 12.7% holding and agrees to a 90-day lock-up on its remaining shares. Eurowag is not party to the transaction and will receive no proceeds from the share sale.
----------
Bridgepoint Group PLC, up 2.3% at 321.22 pence, 12-month range 212.00p-366.68p. Reports "record" first-half underlying results, with underlying management and other fees rising 23% to GBP254.1 million from GBP206.8 million a year before and performance-related earnings more than doubling to GBP120.7 million from GBP57.6 million, lifting underlying Ebitda 78% to GBP227.3 million from GBP128.0 million. Assets under management increases 12% to USD97.3 billion from USD86.6 billion, while fee-paying assets under management jumps 33% to USD58.4 billion from USD44.0 billion. The London-based private equity firm returns a record EUR16.6 billion to fund investors in the first half, compared with EUR8.1 billion in the whole of 2025, and says it has now raised EUR26 billion towards its increased EUR28 billion fundraising target by the end of 2026,.
----------
By Eva Castanedo, Alliance News senior economics reporter
Comments and questions to [email protected]
Copyright 2026 Alliance News Ltd. All Rights Reserved.
Related Shares:
Severn TrentBTExperianVodafoneBritish American TobaccoBurberryAntofagastaPolar CapitalScottish MortgageGlaxosmithklineOcadoHaysMondiPartners Grp ECeres PowerEW GroupRaspberry PiAllianz Technology TrustPacific HorizonBridgepoint